Dr Adam Glaser is a Consultant and Clinical Associate Professor in Paediatric Oncology and the Late-Effects of Cancer in Leeds, where he leads the long-term follow-up programme. Until April 2013 he was; Clinical Director of the National Cancer Survivor Initiative at the Department of Health, England, Late-effects Lead at the Yorkshire Cancer Network and National Clinical Lead and Advisor, Cancer at NHS Improvement.
Adam has extensive experience of the measurement of health-related quality of life and patient reported outcome assessment in survivors of cancer. He has researched and published widely on the late effects of cancer and the assessment of patient reported outcomes.
Adam was involved in the development of the Cancer PROMS Programme at the Department of Health (2010-13). A methodology for the national collection of PROMS on cancer patients was successfully piloted (2011) and subsequently rolled-out to all survivors of colorectal cancer 12-36 months post diagnosis in England (2013).
He is currently a member of ICHOM, the Harvard based international consortium developing guidelines for the standardisation of outcome assessment following prostate cancer, and member of the National Prostate Clinical Audit clinical reference group.